×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Avalo Therapeutics (AVTX) Surges 270% in a Week: Here's Why
Yahoo Finance
Avalo Therapeutics AVTX is a clinical-stage biotechnology company focused on developing therapies targeting immune dysregulation.
2 months ago
Public equity report: Avalo gets makeover with PIPE, acquisition
BioCentury
A PIPE refreshed Avalo's balance sheet as it prepares to move forward a newly acquired program for an inflammatory skin disorder,...
2 months ago
Why Is Avalo Therapeutics (AVTX) Stock Up 326% Today?
InvestorPlace
Avalo Therapeutics stock is up with heavy trading of AVTX shares are completing its acquisition of AlmataBio and securing new funding.
2 months ago
Avalo Therapeutics, Inc. (AVTX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Yahoo News New Zealand
Avalo Therapeutics, Inc. (AVTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming...
4 days ago
Avalo Therapeutics’ Strategic Expansion and Leadership Revamp
TipRanks
An announcement from Avalo Therapeutics (AVTX) is now available. Avalo Therapeutics, Inc. finalized a significant merger with AlmataBio, Inc. on March 27,...
2 months ago
Will Avalo Therapeutics, Inc. (AVTX) Report Negative Q4 Earnings? What You Should Know
Zacks Investment Research
This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more...
2 months ago
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
GlobeNewswire
WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a 1-for-240 reverse...
5 months ago
Avalo drops three rare disease assets amid ongoing challenges
Pharmaceutical Technology
The company will divest the AVTX-800 rare disease compound series to AUG Therapeutics, with an expected completion in Q4 2023.
8 months ago
Avalo Therapeutics stock more than triples on Anti-IL-1β mAb acquisition (NASDAQ:AVTX)
Seeking Alpha
Mar. 27, 2024 4:16 PM ETAvalo Therapeutics, Inc. (AVTX) StockBy: Vansh Agarwal, SA News Editor2 Comments. Science technology concept.
2 months ago
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving ...
markets.businessinsider.com
U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE:REX)...
2 months ago